UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8–K
Current Report Filed Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported): September 6, 2001
Enchira Biotechnology Corporation
(Exact name of registrant as specified in its charter)
| Delaware | 0-21130 | 04-3078857 |
| (State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
| 4200 Research Forest Drive The Woodlands, Texas 77381 | ||
| (Address of principal executive offices and zip code) | ||
| (281) 364-6100 | ||
| (Registrant’s telephone number, including area code) | ||
Item 5. Other Events
On September 6, 2001, Enchira Biotechnology Corporation (the “Company”) issued a press release announcing that it had repurchased shares of its common stock from one of its stockholders in a negotiated transaction.
The press release is filed as an exhibit to this Current Report on Form 8-K and is incorporated by reference herein.
Item 7. Exhibits
Exhibit 99.1 — Press Release
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Enchira Biotechnology Corporation | ||||
| Date: | September 6, 2001 | |||
| By: | /s/ Paul G. Brown, III | |||
| Paul G. Brown, III | ||||
| Vice President, Finance and Administration and Chief Financial Officer | ||||
